Horizon Pharma is going hostile with an all-stock offer for Depomed valued at about $2.1 billion, taking the bid directly to shareholders. Horizon says it has been trying to discuss a deal with Depomed Inc. since March, but that company's board has rejected its proposal.

Topics:  horizon pharma   depomed inc   march   horizon   depomed   hostile   bid   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More World News